Fresenius | FRE - Assets


Fresenius reported EUR41.4B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Akzo Nobel EUR 15.49B 1.53B Mar/2026
Alcon AG USD 31.62B 64M Mar/2026
AstraZeneca USD 114.02B 59M Mar/2026
BASF EUR 76.17B 267M Dec/2025
Bayer EUR 107.94B 3.4B Mar/2026
Beiersdorf EUR 12.76B 166M Dec/2025
DaVita Healthcare Partners USD 17.5B 19.26M Mar/2026
Demant DKK 39.07B 6.43B Dec/2025
E.ON EUR 117.22B 6.53B Mar/2026
Essilor EUR 63.9B 1.97B Dec/2025
Fresenius EUR 41.4B 1.07B Dec/2025
Fresenius Medical Care EUR 31.47B 465.26M Mar/2026
Getinge SEK 63.92B 4.3B Dec/2024
Givaudan CHF 11.86B 587M Dec/2025
GlaxoSmithKline GBP 62.87B 1.75B Mar/2026
GN Store Nord DKK 28.56B 671M Mar/2026
GRIFOLS EUR 20.08B 366M Mar/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Lonza CHF 18.97B 164M Dec/2025
Merck EUR 53.07B 1.54B Mar/2026
Novartis USD 118.53B 7.58B Mar/2026
Philips EUR 27.27B 322M Mar/2026
Roche Holding CHF 100.7B 5.94B Dec/2025
RWE EUR 116.76B 15.05B Mar/2026
Sanofi EUR 128.02B 1.22B Mar/2026
Smith & Nephew USD 10.69B 150M Dec/2025